Adult Acute Myeloid Leukemia — Trials

Adult Acute Myeloid Leukemia — Trials · CancerIndex

Clinical trials

Registered studies

374 studies whose conditions map to this entity or one of its descendants. Status and phase are as posted on ClinicalTrials.gov. 50 studies per page.

Active: 64
Recruiting: 39
Ph III recruiting: 4
Growth YoY: —
Industry share: 17%
Top sponsor: City of Hope Medical Center
Termination share: 36.4%

Computedformula ci-trial-intel-v1 · interventional studies · entity + NCIt descendants · hover a figure for its formulaCompare cancers Terminated studies (72)

clinicaltrialsPublishedShowing 151–173 of 173 studies matching the filters · status and phase as posted by the registrant; each row links to the study record.

NCT	Title	Status	Phase	Enrollment (n)	Sponsor	Countries	Last update	Source
NCT00470197	Flavopiridol, Cytarabine, and Mitoxantrone in Treating Patients With Relapsed or Refractory Acute Leukemia	completed	Phase 1	35	National Cancer Institute (NCI)NIH	1	Sep 30, 2013	clinicaltrials
NCT01159301	Entinostat and Sorafenib Tosylate in Treating Patients With Advanced or Metastatic Solid Tumors or Refractory or Relapsed Acute Myeloid Leukemia	terminated	Phase 1	44	National Cancer Institute (NCI)NIH	1	Sep 19, 2013